Reviving Previous Therapeutics by Recombinant Anaerobic Bifidobacteria

Abstract

Anaerobic bacteria such as clostridia have gained attention for use in anti-cancer therapies. They selectively invade tumor tissue and grow in the hypoxic environment surrounding the tumor cells